REYON Pharmaceutical Co., Ltd. (KRX:102460)
South Korea flag South Korea · Delayed Price · Currency is KRW
12,570
-1,180 (-8.58%)
Last updated: Jun 27, 2025

REYON Pharmaceutical Market Cap

REYON Pharmaceutical has a market cap or net worth of 209.82 billion as of June 27, 2025. Its market cap has decreased by -20.67% in one year.

Market Cap
209.82B
Enterprise Value
406.69B
Revenue
148.04B
Ranking
n/a
PE Ratio
51.99
Stock Price
12,570.00

Market Cap Chart

Since June 10, 2010, REYON Pharmaceutical's market cap has increased from 164.55B to 209.82B, an increase of 27.51%. That is a compound annual growth rate of 1.63%.

History

DateMarket Cap% Change
Jun 27, 2025221.93B-5.76%
Dec 30, 2024235.50B-22.37%
Dec 28, 2023303.36B-21.07%
Dec 29, 2022384.35B-39.10%
Dec 30, 2021631.11B61.64%
Dec 30, 2020390.43B47.64%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Samsung Biologics 70.89T
Celltrion 35.32T
ALTEOGEN 20.33T
Yuhan 7,706.69B
SK Biopharmaceuticals 7,150.00B
HLB Co., Ltd. 6,270.01B
PharmaResearch 5,044.17B
Peptron 4,775.96B
Market Cap Rankings